Multi-omics technologies in gut microbiome research provide a global view of changes in genetic, metabolic and biochemical processes. This approach has now been applied to the gut microbiota in the context of IBD, providing first steps towards a functional understanding of host–microbe interactions during disease pathogenesis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Metabolomic profiling implicates mitochondrial and immune dysfunction in disease syndromes of the critically endangered black rhinoceros (Diceros bicornis)
Scientific Reports Open Access 19 September 2023
-
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
Mucosal Immunology Open Access 09 May 2022
-
Integrated analyses of miRNA and mRNA profiles in leukocytes and serums in traditional Chinese medicine (TCM)-defined Pi-qi-deficiency syndrome and Pi-wei damp-heat syndrome resulting from chronic atrophic gastritis
Chinese Medicine Open Access 06 January 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390, 2769–2778 (2017).
Renz, H. et al. Gene-environment interactions in chronic inflammatory disease. Nat. Immunol. 12, 273 (2011).
Pascal, V. et al. A microbial signature for Crohn’s disease. Gut 66, 813–822 (2017).
Yilmaz, B. et al. Microbial network disturbances in relapsing refractory Crohn’s disease. Nat. Med. 25, 323–336 (2019).
Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662 (2019).
Rath, E., Moschetta, A. & Haller, D. Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis. Nat. Rev. Gastroenterol. Hepatol. 15, 497–516 (2018).
Linge, H. M. et al. The Human CXC Chemokine Granulocyte Chemotactic Protein 2 (GCP-2)/ CXCL6 Possesses Membrane-Disrupting Properties and Is Antibacterial. Antimicrob. Agents Chemother. 52, 2599–2607 (2008).
Jain, U., Otley, A. R., Van Limbergen, J. & Stadnyk, A. W. The Complement System in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 20, 1628–1637 (2014).
Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623 (2018).
Nagao-Kitamoto, H. et al. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Cell. Mol. Gastroenterol. Hepatol. 2, 468–481 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Metwaly, A., Haller, D. Multi-omics in IBD biomarker discovery: the missing links. Nat Rev Gastroenterol Hepatol 16, 587–588 (2019). https://doi.org/10.1038/s41575-019-0188-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-019-0188-9
This article is cited by
-
Metabolomic profiling implicates mitochondrial and immune dysfunction in disease syndromes of the critically endangered black rhinoceros (Diceros bicornis)
Scientific Reports (2023)
-
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
Mucosal Immunology (2022)
-
Integrated analyses of miRNA and mRNA profiles in leukocytes and serums in traditional Chinese medicine (TCM)-defined Pi-qi-deficiency syndrome and Pi-wei damp-heat syndrome resulting from chronic atrophic gastritis
Chinese Medicine (2021)
-
Gut microbiome, liver immunology, and liver diseases
Cellular & Molecular Immunology (2021)
-
Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism
Nature Communications (2020)